Join Us for a Product Characterization Webinar on
September 12th! |
|
|
| Title: | |
Process Impurities: Don’t Let PEI or HCP Derail Your BioTherapy |
| |
| Date: | |
Thursday, September 12, 2019 |
| |
| Time: | |
11:00 AM Eastern Daylight Time |
| |
| Duration: | |
1 hour |
|
|
|
|
| Webinar Summary |
|
|
The manufacturing of a biotherapy involves multiple inputs, ranging in complexity from a transfection reagent to the host cell in which the therapy is manufactured. All of these process components should be removed prior to the therapy being available for human use.
|
 |
|
|
|
During this webinar we will review strategies within product characterization to de-risk the manufacturing process for cell and gene therapies and monoclonal antibodies (mAbs).
|
|
| We will focus on how we effectively detect and characterize: |
|
| • |
polyethylenimine (PEI), used in cell and gene therapy products; and |
| • |
host cell proteins, a factor in mAb therapies and cell and gene therapies. |
|
|
 |
|
|
|
|
